Home
>
National Drug Code (NDC)
>
HAVRIX
HAVRIX - 58160-826-34 - (Hepatitis A Vaccine)
Drug Information of HAVRIX
| Product NDC: | 58160-826 |
| Proprietary Name: | HAVRIX |
| Non Proprietary Name: | Hepatitis A Vaccine |
| Active Ingredient(s): | 1440 [iU]/mL & nbsp; Hepatitis A Vaccine |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HAVRIX
| Product NDC: | 58160-826 |
| Labeler Name: | GlaxoSmithKline Biologicals SA |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103475 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20070413 |
Package Information of HAVRIX
| Package NDC: | 58160-826-34 |
| Package Description: | 1 SYRINGE in 1 CARTON (58160-826-34) > 1 mL in 1 SYRINGE (58160-826-05) |
NDC Information of HAVRIX
| NDC Code | 58160-826-34 |
| Proprietary Name | HAVRIX |
| Package Description | 1 SYRINGE in 1 CARTON (58160-826-34) > 1 mL in 1 SYRINGE (58160-826-05) |
| Product NDC | 58160-826 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Hepatitis A Vaccine |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20070413 |
| Marketing Category Name | BLA |
| Labeler Name | GlaxoSmithKline Biologicals SA |
| Substance Name | HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Strength Number | 1440 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
